Braveheart Bio, Inc. (BRVE)
17.17
-0.24
(-1.41%)
USD |
NASDAQ |
Nov 06, 10:14
Braveheart Bio Shareholders Equity (Quarterly) : 117.61M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 117.61M |
| Date | Value |
|---|---|
| March 31, 2026 | 71.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 23.40B |
| Trulieve Cannabis Corp. | 767.46M |
| Journey Medical Corp. | 32.11M |
| Turn Therapeutics, Inc. | 0.6869M |
| ANI Pharmaceuticals, Inc. | 597.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.96M |
| Total Liabilities (Quarterly) | 9.342M |
| Debt to Equity Ratio | 0.0049 |
| Current Ratio | 13.63 |